What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

To evaluate the efficacy of MDP4 in correcting autoimmune long QT syndrome (LQTS).

March 14, 2026Communications Medicine0 citationsOpen Access

hERG epitope mimic-decoy peptide corrects autoimmune-long QT syndrome in guinea pigs

MCMichael CupelliSUNY Downstate Health Sciences University VGVamsi Krishna Murthy GinjupalliSUNY Downstate Health Sciences University JRJean‐Baptiste ReisqsVA NY Harbor Healthcare System

Key Points

To evaluate the efficacy of MDP4 in correcting autoimmune long QT syndrome (LQTS).
Conducted in vivo treatment with MDP4 in guinea pigs
Assessed QT-interval prolongation recovery
Examined I<sub>Kr</sub> inhibition in vitro
MDP4 treatment resulted in recovery of QT-interval prolongation
Demonstrated I<sub>Kr</sub> inhibition in vitro
Suggests potential for treating autoimmune LQTS in humans

Abstract

Treatment with MDP4 results in recovery of both the QT-interval prolongation in vivo and IKr inhibition in vitro. MDP4 and other conceptually similar molecules may represent an innovative therapeutic approach for autoimmune LQTS in humans, and, prospectively, for other forms of arrhythmogenic autoimmune cardiac channelopathies.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Cupelli et al. (Wed,) studied this question.

synapsesocial.com/papers/69b4b9db18185d8a39801eec https://doi.org/https://doi.org/10.1038/s43856-026-01508-7

Demander à l'IA

Bookmark

View Full Paper